News: MNY Money3 Corp Re-Confirms Guidance Of $35 Mln-$36 Mln NPAT For FY, page-5

First 5 Last

Share
Profile

Follow
Madtrader

590 Posts.

41

17/01/19

17:42

Post #: 37147331
Share

Originally posted by danbradster ↑

Originally posted by Madtrader
I agree and took the opportunity to increase my position in late November (after also reducing it) with the fall in SP on industry sentiment. Always going to be regulatory risk but feels overly priced in to me and as you point out this company has continually grown earnings (seemingly in a responsible way to me and not from what I can see through accounting trickery) and paid dividends. A good blend of positives and value in my personal opinion.

DYOR opinions aren't advice
"Money3 also believes that closing this loophole would benefit MNY and its market position.”

It seems that the regulatory risk is in their favour this time.

Less loans going through less-scrupulous pathways leaves more on the table for MNY. This should be having more of an effect now.

"On 1 November, ASIC stated that its ban on flex commissions in the car finance market commences on 1 November 2018." - "Money3 does not provide flex commissions on its products"

"CAFBA‘s position is that whilst ASIC has removed flex-commissions, a major disadvantage for brokers still remains while the Point of Sale Exemption under the NCCP Act for car dealers still exists."

I don't know if the POS Exemption is being closed or not. Which news article are they referring to?

Expand

Yes agree. I was referring to regulatory risk more generally. I'm not presently concerned and my read of the announcement was also that any move in that particular space would likely benefit MNY.

DYOR

Last edited by Madtrader: 17/01/19
1 Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Chaos reigns markets – so let's take stock of where we're at ahead of December

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 5 more messages in this thread...

First 5 Last

Add MNY (ASX) to my watchlist

News: MNY Money3 Corp Re-Confirms Guidance Of $35 Mln-$36 Mln NPAT For FY, page-5

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Chaos reigns markets – so let's take stock of where we're at ahead of December

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game